FDA Clearance Tracker · K213854
SavvyWire
Last checked: Nov 19, 2026Latest source record: Sep 14, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Sep 14, 2022
Substantially Equivalent
Time to decision
278 days
Received Dec 10, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K213854
- Device name
- SavvyWire
- Applicant
- Opsens, Inc.
- Applicant location
- Quebec, CA
- Received
- Dec 10, 2021
- Decided
- Sep 14, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Wire, Guide, Catheter (DQX)
- Device class
- Class II
- Regulation
- 21 CFR 870.1330
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DQX. The earliest in FDA's data is K760944, decided Dec 10, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K213854
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Opsens, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- OptoMonitor 3510(k)
K251367 · Decided Jan 16, 2026 · 260 days after receipt
Device type: Transducer, Pressure, Catheter Tip (DXO) · Cardiology
- OptoMonitor 3510(k)
K241418 · Decided Feb 12, 2025 · 268 days after receipt
Device type: Transducer, Pressure, Catheter Tip (DXO) · Cardiology
- PacePro Wire510(k)
K240864 · Decided May 24, 2024 · 57 days after receipt
Device type: Wire, Guide, Catheter (DQX) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.